🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our keynote speaker Dr Raghib Ali OBE MD MPH FRCP, the chief medical officer Our Future Health says there’s a lots of opportunities for researchers to work together, and the UK is the best place in the world to do this, with the health system we've got! #Bloodcancersymposium25 #beatingbloodcancer

"Your postcode is as, if not more important than your genetic code" when it comes to your health outcome. Dr Raghib Ali OBE MD MPH FRCP outlines Our Future Health's commitment to diversity to build a representative cohort to help answer vital questions. #bloodcancersymposium25 #beatingbloodcancer

Thanks for Our Future Health attending our #bloodcancersymposium25 at the Royal College of Physicians

Dr Gonia Gozdecka Cambridge Stem Cell Institute gave exciting insights of how metformin could help prevent AML in those with the DNT3A mutation. 👉bit.ly/3Ge3rkZ Because we want to stop people from getting blood cancer at all. #bloodcancersymposium25 #beatingbloodcancer

Now, Professor Claire Edwards from the University of Oxford shares insights about a link between, obesity, ageing and myeloma. Read more about how fat cells interact with 'sleepy cells', waking them up and causing the disease to return👉 bit.ly/407rOr7 #bloodcancersymposium25

So why do MPNs develop? Professor Lesley Anderson Prof Lesley Anderson from University of Aberdeen talks us through how she is identifying small changes in our DNA that might be responsible for causing the disease. 👉bit.ly/3IdClem #bloodcancersymposium25

Great to see so many researchers come together for a day of science and talks, on what is an exciting day for the charity as we announce we're looking to fund £70m of research over the next five years! 💪 #bloodcancersymposium25 #beatingbloodcancer

We're at the Royal College of Psychiatrists sharing findings from the research community about the latest in prevention, early detection and treatments. Read more about our bold new research strategy in the 🧵below!

"We can't reliably spot MPN using conventional methods" Dr Dan Royston is using AI techniques to improve the diagnosis of MPN. 👉bit.ly/44vcsxV Because early detection will improve outcomes for people with blood cancer. #bloodcancersymposium25

Dr Sarra Ryan Ryan Lab talks about her exciting new sequencing technique revealing previously hidden DNA alterations in the blood cells that cause ALL in children. 👉bit.ly/4krD0q2 #bloodcancersymposium25

"The exact immune defects that lead to PTLD are unknown" Dr Heather Long Heather Long at Immunology and Immunotherapy tells us how she is uncovering biomarkers for PTLD, a blood cancer that can develop following a stem cell transplant. 👉bit.ly/3TtRvyq #bloodcancersymposium25

"We need to establish new targeted therapies that can replace or augment existing treatments" This afternoon we kicked off our treatment session with Prof Alex Tonks sharing his research investigating the role of ROS in AML. 👉bit.ly/4lyMY9Y #bloodcancersymposium25

Next up, Dr Charlotte Graham from King's College London who talks us through an exciting new type of CAR-T cell therapy for myeloma. This involves a new rapid production process to produce CAR-T cells in only three days. 👉bit.ly/40I4QHh #bloodcancersymposium25

Prof Michelle West spoke about her group's drug discovery work to target EBV blood cancer cells and leave healthy cells unscathed. 👉bit.ly/4nBMrG1 Because we need to develop new treatments that cure blood cancer for good. #bloodcancersymposium25

Pleasure speaking about our MPN Discovery research project funded by Blood Cancer UK and our MOSAICC study. The study is in the processing of closing UK sites after recruiting 634 cases and 197 controls.

Closing our treatment session we heard from Prof Terry Rabbitts and Dr Daniel Sanchez-Guzman from The ICR who talked us through their use of antibody engineering in their quest to develop a new treatment for T-ALL. 👉bit.ly/4nB6Evy #bloodcancersymposium25

"It can be greatly beneficial to involve people affected by blood cancer in your research and we can help you." We hear from Lisa Whittaker , our Research Involvement Lead. This is a key part of our new Research Strategy 👉bit.ly/4lCE0s7 #bloodcancersymposium25

Wow, what an amazing day with so many incredible speakers. You are getting us closer to the day where no-one dies from blood cancer or its treatments. Thank you all so much. #bloodcancersymposium25

We're so pleased to fund early career researchers like Nisha. Funding the next generation of talent is at the core of our research strategy over the next 5 years!

New blog with Cancer Research UK Lead Research Nurse Anne Croudass, thanks so much for sharing NIHR ARC South London #ppi #involvement #cancerresearch CRUK RadNet City of London Biomedical Engineering & Imaging Sciences Blood Cancer UK Research arc-sl.nihr.ac.uk/news-insights/…